Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
PSYCH Symposium: London 2023 - ticket prices rise at midnight, Negev Capital confident big pharma will embrace psychedelics, Fresh insights into the mechanism of action of psychedelic medicines.
CDPRG discusses the UK’s Reschedule Psilocybin campaign, MP Charlotte Nichols speaking at PSYCH Symposium: London 2023, Reunion Neuroscience to be acquired for US$13.1 million.
The value of patents in psychedelic medicine, First facilitators of psilocybin services graduate in Oregon, Small Pharma releases data from Phase II DMT study.
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
Subscribe to the Psychedelics Newsletter
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.